Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.47 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | CPB2 | Q96IY4 | 9/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | GGT1 | P19440 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1168511 | 1.00 | GSR (0.53) | GSRFOLH1RNPEPSLC6A5MMP2 | |
| SCHEMBL28786641 | 1.00 | GSR (0.53) | GSRFOLH1RNPEPSLC6A5MMP2 | |
| SCHEMBL10430391 | 0.94 | FOLH1 (0.46) | GSRFOLH1RNPEPSLC6A5MMP2 | |
| SCHEMBL6616072 | 0.94 | FOLH1 (0.46) | GSRFOLH1RNPEPSLC6A5MMP2 | |
| SCHEMBL27529124 | 0.94 | FOLH1 (0.46) | GSRFOLH1RNPEPSLC6A5MMP2 | |
| Lysine SCHEMBL14776740 | 0.93 | GSR (0.67) | GSRFOLH1RNPEPSLC6A5MMP2 | |
| Acrylamide SCHEMBL28112667 | 0.90 | FOLH1 (0.45) | GSRFOLH1RNPEPSLC6A5MMP2 | |
| SCHEMBL13067469 | 0.88 | FOLH1 (0.54) | GSRFOLH1RNPEPSLC6A5MMP2 | |
| SCHEMBL13218612 | 0.85 | GSR (0.44) | GSRFOLH1RNPEPSLC6A5MMP2 | |
| SCHEMBL18105654 | 0.85 | GSR (0.44) | GSRFOLH1RNPEPSLC6A5MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114624362-A | Kit for detecting advanced glycosylation end products in serum and application thereof | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 2022-06-14 | — | — | CN | claimed |
| CN-112195216-B | Method for evaluating antioxidant stress benefit of active compound based on bacterial model | 南京航空航天大学 | 2022-06-07 | — | — | CN | claimed |
| EP-2427775-B1 | PEPTIDE LIGANDS OF SOMATOSTATIN RECEPTORS | BCN PEPTIDES SA (ES) | 2021-08-11 | — | — | EP | claimed |
| CN-112195216-A | Method for evaluating antioxidant stress benefit of active compound based on bacterial model | 南京航空航天大学 | 2021-01-08 | — | — | CN | claimed |
| JP-61140552-A | — | — | None | — | — | JP | disclosed |
| CN-121789914-A | Machine learning model for predicting traditional Chinese medicine wet syndrome and application thereof | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 2026-04-03 | — | — | CN | disclosed |
| EP-4473841-B1 | PROCESS FOR PRODUCING AN ANIMAL FEED AND SAID ANIMAL FEED | TRACELESS MAT GMBH (DE) | 2025-12-03 | — | — | EP | disclosed |
| US-20240407397-A1 | PROCESS FOR PRODUCING AN ANIMAL FEED | TRACELESS MATERIALS GMBH (DE) | 2024-12-12 | — | — | US | disclosed |
| EP-4473841-A1 | PROCESS FOR PRODUCING AN ANIMAL FEED | Traceless Materials GmbH (DE) | 2024-12-11 | — | — | EP | disclosed |
| CN-119097049-A | Processing method for producing animal feed | 无痕材料公司 | 2024-12-10 | — | — | CN | disclosed |
| US-20240366738-A1 | MOLECULAR VACCINES FOR INFECTIOUS DISEASE | AGILENT TECHNOLOGIES INC (US) | 2024-11-07 | — | — | US | disclosed |
| US-11992518-B2 | Molecular vaccines for infectious disease | AGILENT TECHNOLOGIES, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| CN-1251521-A | Compounds and methods for therapeutic intervention in preventing diabetic complications | FOX CHASE CANCER CENTER (US) | 2000-04-26 | — | — | CN | disclosed |
| WO-1999064561-A2 | METHOD FOR ASSESSING A DIABETIC'S RISK OF EXPERIENCING A DIABETES-ASSOCIATED PATHOLOGIC CONDITION | FOX CHASE CANCER CENTER (US) | 1999-12-16 | — | — | WO | disclosed |
| WO-1998033492-A1 | COMPOUNDS AND METHODS FOR THERAPEUTIC INTERVENTION IN PREVENTING DIABETIC COMPLICATIONS | FOX CHASE CANCER CENTER (US) | 1998-08-06 | — | — | WO | disclosed |
| CN-1161374-A | Fructosyl amino acid oxidase and process for producing same | KYOTO DAIICHI KAGAKU KK (JP) | 1997-10-08 | — | — | CN | disclosed |
| CN-1143111-A | Fructoamino-acid-oxidase and its producing method | KYOTO DAIICHI KAGAKU KK (JP) | 1997-02-19 | — | — | CN | disclosed |
| US-5541159-A | PEPTIDE HORMONE ANTAGONIST | SANDOZ LTD. (CH) | 1996-07-30 | — | — | US | disclosed |
| WO-1989009786-A1 | PEPTIDE DERIVATIVES | SANDOZ AG (CH) | 1989-10-19 | — | — | WO | disclosed |
| JP-S61140552-A | PRODUCTION OF N2-FORMYLLYSINE | TORAY IND INC | 1986-06-27 | — | — | JP | disclosed |